AKT1 and melanoma: The presence of both alterations is responsible for development of metastatic lesions in a mouse model [51] and the inhibition of both signaling (BRAF and PI3K/AKT) caused a regression of melanoma, but upon arrest of drug administration, melanoma restart to grow indicating the presence of long-lived initiating cells.